Login
$DMRA
$22.06 -$0.44 (1.93%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Jennifer Jarrett Also a director
President, Chief Executive Officer and Director
55 Not stated Not reported
Brian Burkavage
Principal Financial Officer and Principal Accounting Officer
Title from the Form 8-K dated May 1, 2026
Not stated Not stated Not reported
Sherwin Sattarzadeh
Chief Operating Officer
47 Since 2026
this year
Not reported
Becker Hewes
Chief Medical Officer
60 Since 2026
this year
Not reported
Garrett Winslow
General Counsel and Corporate Secretary
47 Since 2021
5 years
$854,755

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
1 of 2
stated in the proxy; 4 not stated
Average tenure
0.5 years
from year joined
CEO also chairs the board
No
Peter Harwin
Director Age On board Independent Committees Other public boards 2025 pay Source
Peter Harwin
40 2025
1 year
Independent None stated Spyre Therapeutics, Inc., Oruka Therapeutics, Inc. $6,726
Jennifer Jarrett
55 2026
this year
Not independent None stated Syndax Pharmaceuticals, Inc. Paid as CEO
Michael Landsittel
54 2026
this year
Not stated None stated None stated Not stated
Cameron Turtle
36 2026
this year
Not stated None stated Spyre Therapeutics, Inc. Not stated
Christopher Cain, Ph.D.
42 2025
1 year
Not stated None stated Viridian Therapeutics, Inc. $7,099
Julianne Bruno
40 2025
1 year
Not stated
Compensation Committee
None stated $8,594

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support